EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Sarcoidosis: a state-of-the-art review

Jelle R Miedema, Francesco Bonella iD, Katharina Buschulte, Daniel A Culver, Florence Jeny iD, Ogugua Ndili Obi iD, Natalia V Rivera iD, Paolo Spagnolo, Marcel Veltkamp, Marlies Wijsenbeek

European Respiratory Journal · 2026-02 · 67 (2) · 2501324

DOI: 10.1183/13993003.01324-2025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Respiratory Journal, online erschienen am 13.11.2025. Verfasst von Jelle R Miedema und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence for ILD and Sarcoidosis, member of European Reference Network-Lung, Department of Respiratory Medicine, Erasmus University Medic…. Hauptthemen laut MEDLINE: Sarcoidosis, Sarcoidosis, Pulmonary. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 206 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcoidosis is a complex systemic granulomatous disease that can affect multiple organs, with pulmonary involvement being the most common. Its pathogenesis involves genetic predisposition and chronic immune dysregulation, which increase susceptibility to environmental or endogenous triggers, leading to an aberrant immune response. Imaging plays a central role in diagnosis and has evolved from traditional chest radiography Scadding staging to a computed tomography-based classification and radiomics that improves disease phenotyping. Due to its variable presentation, diagnosing sarcoidosis and attributing symptoms to the disease can be challenging; therefore, awareness and consideration of alternative diagnoses remain essential. The clinical course of sarcoidosis is unpredictable; many patients do not require therapy. Treatment decisions must be individualised, balancing disease severity, risk of organ damage, quality of life and potential toxicity of medication. However, the lack of both reliable prognostic tools and clear criteria for high-risk cases contributes to substantial heterogeneity in disease management. While the guidelines still recommend corticosteroids as first-line treatment, recent data show that methotrexate and prednisone have comparable effects on pulmonary function, although differ in side-effect profiles and time to efficacy. For refractory cases, second-line therapy involves combining or switching drugs, with anti-tumour necrosis factor agents representing third-line options, ideally in expert hands. Novel therapies targeting pathways involved in disease pathogenesis are under investigation. There is growing consensus on the need to revise current treatment algorithms to minimise corticosteroid use and adopt more evidence-based approaches. Future priorities include identifying prognostic biomarkers, refining trial design and establishing meaningful end-points to improve individualised care for the heterogeneous population of patients with sarcoidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcoidosisSarcoidosis, PulmonaryHumansTomography, X-Ray ComputedMethotrexatePrognosisAdrenal Cortex HormonesQuality of LifePrednisone

Substanzen

MethotrexateAdrenal Cortex HormonesPrednisone

Autor:innen und Institutionen

  • Center of Excellence for ILD and Sarcoidosis, member of European Reference Network-Lung, Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Center for Interstitial and Rare Lung Diseases, member of European Reference Network-Lung, Pneumology Department, Ruhrlandklinik University Hospital, University of Duisburg-Essen, Essen, Germany.
  • Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, member of European Reference Network-Lung, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.
  • Department of Pulmonary and Critical Care Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Pulmonology, AP-HP, Avicenne University Hospital, INSERM UMR 1272, member of European Reference Network-Lung, University Sorbonne Paris Nord, Bobigny, France.
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Brody School of Medicine, East Carolina University, Greenville, NC, USA.

ORCID-Profile: Francesco Bonella, Florence Jeny, Ogugua Ndili Obi, Natalia V Rivera

Zitieren

APA

Miedema, J. R., Bonella, F., Buschulte, K., Culver, D. A., Jeny, F., Obi, O. N., Rivera, N. V., Spagnolo, P., Veltkamp, M., & Wijsenbeek, M. (2026). Sarcoidosis: a state-of-the-art review. European Respiratory Journal, 67(2), 2501324. https://doi.org/10.1183/13993003.01324-2025

Vancouver

Miedema JR, Bonella F, Buschulte K, Culver DA, Jeny F, Obi ON, et al. Sarcoidosis: a state-of-the-art review. European Respiratory Journal. 2026;67(2):2501324. doi:10.1183/13993003.01324-2025

BibTeX
@article{Miedema2026,
  author = {Miedema, Jelle R and Bonella, Francesco and Buschulte, Katharina and Culver, Daniel A and Jeny, Florence and Obi, Ogugua Ndili and Rivera, Natalia V and Spagnolo, Paolo and Veltkamp, Marcel and Wijsenbeek, Marlies},
  title = {Sarcoidosis: a state-of-the-art review},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {67},
  number = {2},
  pages = {2501324},
  doi = {10.1183/13993003.01324-2025}
}
Kostenlos starten →